M
Michael Olausson
Researcher at Sahlgrenska University Hospital
Publications - 271
Citations - 7915
Michael Olausson is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 45, co-authored 269 publications receiving 7143 citations. Previous affiliations of Michael Olausson include University of Gothenburg & University of Valencia.
Papers
More filters
Journal ArticleDOI
Livebirth after uterus transplantation
Mats Brännström,Liza Johannesson,Hans Bokström,Niclas Kvarnström,Johan Mölne,Pernilla Dahm-Kähler,Anders Enskog,Milan Milenkovic,Jana Ekberg,Cesar Diaz-Garcia,Markus Gäbel,Ash Hanafy,Henrik Hagberg,Henrik Hagberg,Henrik Hagberg,Michael Olausson,Lars Nilsson +16 more
TL;DR: This report is a proof-of-concept for uterus transplantation as a treatment for uterine factor infertility and shows the feasibility of live uterus donation, even from a postmenopausal donor.
Journal ArticleDOI
First clinical uterus transplantation trial: a six-month report
Mats Brännström,Liza Johannesson,Pernilla Dahm-Kähler,Anders Enskog,Johan Mölne,Niclas Kvarnström,Cesar Diaz-Garcia,Ashraf Hanafy,Cecilia Lundmark,Janusz Marcickiewicz,Markus Gäbel,Klaus Groth,Randa Akouri,Saskia Eklind,Jan Holgersson,Andreas Tzakis,Michael Olausson +16 more
TL;DR: The results demonstrate the feasibility of live-donor UTx with a low-dose immunosuppressive protocol, and this type of transplantation may become a treatment of absolute uterine-factor infertility (AUFI).
Journal ArticleDOI
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool.
Xavier Rogiers,Massimo Malagó,Karim A. Gawad,Karl W. Jauch,Michael Olausson,Wolfram T. Knoefel,M Gundlach,Atef F. Bassas,Lutz Fischer,Martina Sterneck,Martin Burdelski,Christoph E. Broelsch +11 more
TL;DR: In situ split-liver transplantation renders graft reduction alone obsolete and opens a donor pool for adults to receive right lobes safely and allows for long-distance sharing between pediatric and adult liver transplant units.
Journal ArticleDOI
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.
J. Peter A. Lodge,Sven Jonas,Robert M Jones,Michael Olausson,José Mir‐Pallardo,Soeren Soefelt,Juan Carlos García-Valdecasas,Vivian C. McAlister,Darius F. Mirza +8 more
TL;DR: In conclusion, use of rFVIIa during OLT significantly reduced the number of patients requiring RBC transfusion and there was no increase in thromboembolic events with rF VIIa administration compared with placebo.
Journal ArticleDOI
Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
B Brandsaeter,Helena Isoniemi,Ulrika Broomé,Michael Olausson,Lars Bäckman,Bent Adel Hansen,Erik Schrumpf,Antti Oksanen,Bo-Göran Ericzon,Krister Höckerstedt,Heikki Mäkisalo,Preben Kirkegaard,Styrbjörn Friman,Kristian Bjøro +13 more
TL;DR: Predictors of hepatobiliary malignancy and patient survival rates have been analysed and cholangiocarcinoma is regarded as a contraindication to liver transplantation (LTX), PSC patients with cholangsiocARCinoma had a 35% 5-year survival following transplantation.